Compare DLTH & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLTH | PDSB |
|---|---|---|
| Founded | 1989 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.1M | 46.0M |
| IPO Year | 2015 | N/A |
| Metric | DLTH | PDSB |
|---|---|---|
| Price | $2.27 | $0.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $9.00 |
| AVG Volume (30 Days) | 184.3K | ★ 604.5K |
| Earning Date | 12-16-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $590,561,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.24 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.58 | $0.70 |
| 52 Week High | $4.66 | $2.20 |
| Indicator | DLTH | PDSB |
|---|---|---|
| Relative Strength Index (RSI) | 33.47 | 48.52 |
| Support Level | $2.88 | $0.86 |
| Resistance Level | $3.36 | $1.13 |
| Average True Range (ATR) | 0.29 | 0.08 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 8.48 | 41.19 |
Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.